{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:34:50Z","timestamp":1762252490907,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T00:00:00Z","timestamp":1483056000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007063","name":"University of Delhi","doi-asserted-by":"publisher","award":["DU R& D 2014-2015"],"award-info":[{"award-number":["DU R& D 2014-2015"]}],"id":[{"id":"10.13039\/501100007063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11030-016-9714-7","type":"journal-article","created":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T08:54:16Z","timestamp":1483088056000},"page":"163-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Design, synthesis, in silico and biological evaluation of novel 2-(4-(4-substituted piperazin-1-yl)benzylidene)hydrazine carboxamides"],"prefix":"10.1007","volume":"21","author":[{"given":"Shikha","family":"Kumari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandra Bhushan","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danish","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amresh","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Imtaiyaz","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,30]]},"reference":[{"key":"9714_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran CT (2008) Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 7:168\u2013181. doi:\n                        10.1038\/nrd2467","journal-title":"Nat Rev Drug Discov"},{"key":"9714_CR2","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2174\/156802607780636753","volume":"7","author":"SA Zimmerman","year":"2007","unstructured":"Zimmerman SA, Ferry JG, Supuran CT (2007) Inhibition of the archaeal \n                        $$\\beta $$\n                        \n                            \n                                            \n                                \u03b2\n                            \n                        \n                    -class (Cab) and \n                        $$\\gamma $$\n                        \n                            \n                                            \n                                \u03b3\n                            \n                        \n                    -class (Cam) carbonic anhydrases. Curr Top Med Chem 7:901\u2013908. doi:\n                        10.2174\/156802607780636753","journal-title":"Curr Top Med Chem"},{"key":"9714_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/14756360310001656736","volume":"19","author":"S Beydemir","year":"2004","unstructured":"Beydemir S, Gulcin I (2004) Effects of melatonin on carbonic anhydrase from human erythrocytes in vitro and from rat erythrocytes in vivo. J Enzyme Inhib Med Chem 19:193\u2013197. doi:\n                        10.1080\/14756360310001656736","journal-title":"J Enzyme Inhib Med Chem"},{"key":"9714_CR4","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","volume":"20","author":"CT Supuran","year":"2010","unstructured":"Supuran CT (2010) Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 20:3467\u20133474. doi:\n                        10.1016\/j.bmcl.2010.05.009","journal-title":"Bioorg Med Chem Lett"},{"key":"9714_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrd3554","volume":"10","author":"D Neri","year":"2011","unstructured":"Neri D, Supuran CT (2011) Interfering with pH regulation in tumors as a therapeutic strategy. Nat Rev Drug Discov 10:767\u2013777. doi:\n                        10.1038\/nrd3554","journal-title":"Nat Rev Drug Discov"},{"key":"9714_CR6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1517\/17460441.2013.795145","volume":"8","author":"G Simone De","year":"2013","unstructured":"De Simone G, Alterio V, Supuran CT (2013) Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors. Expert Opin Drug Discov 8:793\u2013810. doi:\n                        10.1517\/17460441.2013.795145","journal-title":"Expert Opin Drug Discov"},{"key":"9714_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3109\/21691401.2013.794352","volume":"42","author":"MO Karatas","year":"2014","unstructured":"Karatas MO, Alici B, Cakir U, Cetinkaya E, Demir D, Ergun A, Gencer N, Arslan O (2014) New coumarin derivatives as carbonic anhydrase inhibitors. Artif Cells Nanomed Biotechnol 42:192\u2013198. doi:\n                        10.3109\/21691401.2013.794352","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"9714_CR8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1021\/acs.jmedchem.5b01720","volume":"59","author":"M Ferraroni","year":"2016","unstructured":"Ferraroni M, Carta F, Scozzafava A, Supuran CT (2016) Thioxocoumarins show an alternative carbonic anhydrase inhibition mechanism compared to coumarins. J Med Chem 59:462\u2013473. doi:\n                        10.1021\/acs.jmedchem.5b01720","journal-title":"J Med Chem"},{"key":"9714_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1021\/jm901287j","volume":"53","author":"A Maresca","year":"2010","unstructured":"Maresca A, Temperini C, Pochet L, Masereel B, Scozzafava A, Supuran CT (2010) Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem 53:335\u2013344. doi:\n                        10.1021\/jm901287j","journal-title":"J Med Chem"},{"key":"9714_CR10","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1021\/ml500140t","volume":"5","author":"J Pichake","year":"2014","unstructured":"Pichake J, Kharkar PS, Ceruso M, Supuran CT, Toraskar MP (2014) Carbonic anhydrase inhibitors: design, synthesis, and biological evaluation of novel sulfonyl semicarbazide derivatives. ACS Med Chem Lett 5:793\u2013796. doi:\n                        10.1021\/ml500140t","journal-title":"ACS Med Chem Lett"},{"key":"9714_CR11","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1021\/ja809683v","volume":"131","author":"A Maresca","year":"2009","unstructured":"Maresca A, Temperini C, Vu H, Pham NB, Poulsen SA, Scozzafava A, Quinn RJ, Supuran CT (2009) Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 131:3057\u20133062. doi:\n                        10.1021\/ja809683v","journal-title":"J Am Chem Soc"},{"key":"9714_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejmech.2011.12.022","volume":"49","author":"D Ekinci","year":"2012","unstructured":"Ekinci D, Cavdar H, Durdagi S, Talaz O, Senturk M, Supuran CT (2012) Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b]indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV and VI. Eur J Med Chem 49:68\u201373. doi:\n                        10.1016\/j.ejmech.2011.12.022","journal-title":"Eur J Med Chem"},{"key":"9714_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3109\/14756366.2013.879656","volume":"30","author":"N Korkmaz","year":"2015","unstructured":"Korkmaz N, Obaidi OA, Senturk M, Astley D, Ekinci D, Supuran CT (2015) Synthesis and biological activity of novel thiourea derivatives as carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 30:75\u201380. doi:\n                        10.3109\/14756366.2013.879656","journal-title":"J Enzyme Inhib Med Chem"},{"key":"9714_CR14","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.bmc.2012.09.027","volume":"21","author":"O Talaz","year":"2013","unstructured":"Talaz O, Cavdar H, Durdagi S, Azak H, Ekinci D (2013) Synthesis of 1,4-bis(indolin-1-ylmethyl)benzene derivatives and their structure-activity relationships for the interaction of human carbonic anhydrase isoforms I and II. Bioorg Med Chem 21:1477\u20131482. doi:\n                        10.1016\/j.bmc.2012.09.027","journal-title":"Bioorg Med Chem"},{"key":"9714_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1517\/17425255.2016.1154534","volume":"12","author":"CT Supuran","year":"2016","unstructured":"Supuran CT (2016) Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. Expert Opin Drug Metab Toxicol 12:423\u2013431. doi:\n                        10.1517\/17425255.2016.1154534","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"9714_CR16","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.1016\/j.bmc.2015.10.018","volume":"23","author":"A Karioti","year":"2015","unstructured":"Karioti A, Ceruso M, Carta F, Bilia AR, Supuran CT (2015) New natural product carbonic anhydrase inhibitors incorporating phenol moieties. Bioorg Med Chem 23:7219\u20137225. doi:\n                        10.1016\/j.bmc.2015.10.018","journal-title":"Bioorg Med Chem"},{"key":"9714_CR17","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.4155\/fmc.15.71","volume":"7","author":"CT Supuran","year":"2015","unstructured":"Supuran CT, Winum JY (2015) Carbonic anhydrase IX inhibitors in cancer therapy: an update. Future Med Chem 7:1407\u20131414. doi:\n                        10.4155\/fmc.15.71","journal-title":"Future Med Chem"},{"key":"9714_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ejmech.2015.07.026","volume":"102","author":"M Shaquiquzzaman","year":"2015","unstructured":"Shaquiquzzaman M, Verma G, Marella A, Akhter M, Akhtar W, Khan MF, Tasneem S, Alam MM (2015) Piperazine scaffold: a remarkable tool in generation of diverse pharmacological agents. Eur J Med Chem 102:487\u2013529. doi:\n                        10.1016\/j.ejmech.2015.07.026","journal-title":"Eur J Med Chem"},{"key":"9714_CR19","doi-asserted-by":"publisher","first-page":"24491","DOI":"10.1039\/C5RA26939C","volume":"6","author":"CB Mishra","year":"2016","unstructured":"Mishra CB, Mongre RJ, Kumari S, Jeong DJ, Tiwari M (2016) Synthesis, in vitro and in vivo anticancer activity of novel 1-(4-imino-1-substituted-1H pyrazolo[3,4-d] pyrimidin-5(4H)-yl)urea derivatives. RSC Adv 6:24491\u201324500. doi:\n                        10.1039\/C5RA26939C","journal-title":"RSC Adv"},{"key":"9714_CR20","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.bmcl.2015.01.004","volume":"25","author":"S Kumari","year":"2015","unstructured":"Kumari S, Mishra CB, Tiwari M (2015) Design, synthesis and pharmacological evaluation of N-[4-(4-(alkyl\/aryl\/heteroaryl)-piperazin-1-yl)-phenyl]-carbamic acid ethyl ester derivatives as novel anticonvulsant agents. Bioorg Med Chem Lett 25:1092\u20131099. doi:\n                        10.1016\/j.bmcl.2015.01.004","journal-title":"Bioorg Med Chem Lett"},{"key":"9714_CR21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ejmech.2013.09.027","volume":"69","author":"J Slawinski","year":"2013","unstructured":"Slawinski J, Szafranski K, Vullo D, Supuran CT (2013) Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Eur J Med Chem 69:701\u2013710. doi:\n                        10.1016\/j.ejmech.2013.09.027","journal-title":"Eur J Med Chem"},{"key":"9714_CR22","doi-asserted-by":"publisher","first-page":"16233","DOI":"10.1073\/pnas.0908301106","volume":"106","author":"V Alterio","year":"2009","unstructured":"Alterio V, Hilvo M, Di Fiore A, Supuran CT, Pan P, Parkkila S, Scaloni A, Pastorek J, Pastorekova S, Pedone C, Scozzafava A, Monti SM, De Simone G (2009) Crystal structure of the catalytic domain of the tumor-associated human carbonicanhydrase IX. Proc Natl Acad Sci USA 106:16233\u201316238. doi:\n                        10.1073\/pnas.0908301106","journal-title":"Proc Natl Acad Sci USA"},{"key":"9714_CR23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/0141-8130(90)90040-H","volume":"12","author":"J Vidgren","year":"1990","unstructured":"Vidgren J, Liljas A, Walker NP (1990) Refined structure of the acetazolamidecomplex of human carbonic anhydrase II at 1.9\u00a0A. Int J Biol Macromol 12:342\u2013344. doi:\n                        10.1016\/0141-8130(90)90040-H","journal-title":"Int J Biol Macromol"},{"key":"9714_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0168-8278(00)80417-1","volume":"32","author":"D Larrey","year":"2000","unstructured":"Larrey D (2000) Drug-induced liver diseases. J Hepatol 32:77\u201388. doi:\n                        10.1016\/S0168-8278(00)80417-1","journal-title":"J Hepatol"},{"key":"9714_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jmgm.2016.01.006","volume":"64","author":"S Kumari","year":"2016","unstructured":"Kumari S, Idrees D, Mishra CB, Prakash A, Wahiduzzaman Ahmad F, Md Hassan I, Tiwari M (2016) Design and synthesis of a novel class of carbonic anhydrase-IX inhibitor 1-(3-(phenyl\/4-fluorophenyl)-7-imino-3H-[1,2,3]triazolo[4,5d]pyrimidin6(7H)yl)urea. J Mol Graph Model 64:101\u2013109. doi:\n                        10.1016\/j.jmgm.2016.01.006","journal-title":"J Mol Graph Model"},{"key":"9714_CR26","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1002\/jcc.21478","volume":"31","author":"J Fuhrmann","year":"2010","unstructured":"Fuhrmann J, Rurainski A, Lenhof HP, Neumann D (2010) A new Lamarckian genetic algorithm for flexible ligand-receptor docking. J Comput Chem 31:1911\u20131918. doi:\n                        10.1002\/jcc.21478","journal-title":"J Comput Chem"},{"key":"9714_CR27","doi-asserted-by":"publisher","unstructured":"Lill MA, Danielson ML (2011) Computer-aided drug design platform using PyMOL. J Comput Aided Mol Des 25:13\u201319. doi:\n                        10.1007\/s10822-010-9395-8","DOI":"10.1007\/s10822-010-9395-8"},{"key":"9714_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pharep.2015.08.013","volume":"68","author":"S Kumari","year":"2016","unstructured":"Kumari S, Mishra CB, Tiwari M (2016) Pharmacological evaluation of novel 1-[4-(4-benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-phenyl]-3-phenyl-urea as potent anticonvulsant and antidepressant agent. Pharmacol Rep 68:250\u2013258. doi:\n                        10.1016\/j.pharep.2015.08.013","journal-title":"Pharmacol Rep"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-016-9714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11030-016-9714-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-016-9714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T09:21:09Z","timestamp":1486545669000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11030-016-9714-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,30]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["9714"],"URL":"https:\/\/doi.org\/10.1007\/s11030-016-9714-7","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"type":"print","value":"1381-1991"},{"type":"electronic","value":"1573-501X"}],"subject":[],"published":{"date-parts":[[2016,12,30]]}}}